Deciphera Pharmaceuticals · 2 weeks ago
Director, New Product Planning
Waltham, MA
Full-time
Onsite
Director/Executive
$198K/yr - $273K/yr
12+ years expDeciphera Pharmaceuticals is seeking an experienced, highly strategic Director of New Product Planning to shape the future of their clinical-stage pipeline. This role involves partnering cross-functionally to generate and communicate commercial strategies for early and late-stage assets, while also leading competitive intelligence efforts across targeted disease areas.
BiotechnologyHealth CareMedicalPharmaceuticalTherapeutics
Responsibilities
Partner with R&D, clinical, medical, and commercial functions to build development, market entry, and integrated strategies for pre-clinical and clinical assets
Provide high-quality commercial evaluation and strategic input for Phase 2+ assets and lifecycle management
Refine indication strategy and contribute to clinical development planning for early-stage programs
Develop commercial landscape assessments, indication prioritization, and strategic recommendations for Phase 1 assets
Shape near-, mid-, and long-term commercialization plans to maximize asset value
Collaborate with Investor Relations and Corporate Communications to ensure accurate, compelling external messaging
Synthesize and communicate insights and strategy to program teams, portfolio committees, and senior leadership
Lead continuous collection, synthesis, and communication of competitive intelligence for each program
Monitor and communicate critical market events, ensuring timely strategic alignment within program teams
Coordinate primary and secondary intelligence gathering at medical congresses, earnings calls, and industry meetings
Develop pre- and post-conference summaries and insight presentations
Contribute to global development planning and influence portfolio strategy decisions
Support ongoing asset prioritization, annual strategic planning, and long-range portfolio assessments
Participate in evaluations of in-licensing, out-licensing, and partnership opportunities
Present recommendations to senior leadership and cross-functional governance bodies
Qualification
Required
Bachelor's degree in business, life sciences, or related discipline
12+ years of biopharmaceutical industry experience, including 3–5 years in new product planning, strategic planning, product launch leadership, or related functions
Strong scientific literacy and ability to translate clinical data into commercial insights
Extensive experience with global drug development, commercial launches, and lifecycle strategy
Significant experience with market research and competitive intelligence methodologies
Exceptional strategic thinking, collaboration, communication, and executive-level presentation skills
Proven ability to influence cross-functional teams and senior leadership
Strong organizational skills, ability to manage multiple priorities, and meticulous attention to detail
Preferred
Advanced degree (MBA, MPH, PharmD, PhD)
Experience in hematology/oncology development and commercialization
Experience with emerging market commercialization (e.g., South America, Eastern/Central Europe)
Background in scaling an organization from regional commercial focus to multi-franchise global footprint
Experience working with Japanese business culture and norms
Benefits
Competitive salary and annual bonus.
Comprehensive benefits package including medical, dental, vision insurance, 401(k) retirement plan with company match, and more.
Generous parental leave and family planning benefits.
Outstanding culture and opportunities for personal and professional growth.
Company
Deciphera Pharmaceuticals
Deciphera Pharmaceuticals focuses on improving kinase inhibitor treatments.
201-500 employees
Funding
Current Stage
Public CompanyTotal Funding
$1.01BKey Investors
SV Health InvestorsNew Leaf Venture Partners
2024-04-29Acquired
2023-01-19Post Ipo Equity· $125M
2022-04-27Post Ipo Equity· $172.5M
Leadership Team
Tucker Kelly
EVP & Chief Financial Officer
Lisa Amaya Price
SVP and Chief Human Resources Officer
Recent News
2025-12-10
2025-11-19
Company data provided by crunchbase